Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2007
11/06/2007US7291624 Enzyme inhibitors as drugs for cardiovascular disorders, aids, alzheimers disease or urogenital disorders
11/06/2007US7291606 Compositions and methods for identifying agents which regulate chromosomal stability, gene activation and aging
11/06/2007US7291605 Methods of treating various cancers using melanoma differentiation associated protein-7
11/06/2007US7291603 Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations
11/06/2007US7291495 β-Secretase variant
11/06/2007US7291492 Histone deactylase for use in identifying modulators for prevention and treatment of cell proliferative disorders
11/06/2007US7291454 Comprises antisense olignucleotides, ribozymes, DNA and guide sequences; animal models; genetic engineering; for use in drug screening
11/06/2007US7291330 MD-1 inhibitors as immune suppressants
11/06/2007CA2182795C Superactive vip antagonists
11/06/2007CA2170236C Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes
11/01/2007WO2007124322A1 Inhibitors of c-fms kinase
11/01/2007WO2007124321A1 Inhibitors of c-fms kinase
11/01/2007WO2007124319A1 Inhibitors of c-fms kinase
11/01/2007WO2007124318A1 Inhibitors of c-fms kinase
11/01/2007WO2007124316A1 Heterocyclic compounds as inhibitors of c-fms kinase
11/01/2007WO2007124288A1 Indazole compounds and methods for inhibition of cdc7
11/01/2007WO2007124274A1 Treating neoplasms
11/01/2007WO2007124221A1 Methods of treating cell proliferative disorders by using pyrimidinediamine compounds
11/01/2007WO2007124077A2 Immunoglobulin constant region domains with enhanced stability
11/01/2007WO2007123936A1 Novel heteroaryl-substituted arylaminopyridine derivatives as mek inhibitors
11/01/2007WO2007123516A1 C-fms kinase inhibitors
11/01/2007WO2007123468A1 Polymer-based anti-cancer agents
11/01/2007WO2007123274A1 Novel marker for sensitivity against sulfonamide compound
11/01/2007WO2007123044A1 Licorice polyphenol preparation
11/01/2007WO2007123027A1 Anti-cancer agent comprising cyathane derivative
11/01/2007WO2007122975A1 Hgf precursor protein mutant and activated form thereof
11/01/2007WO2007122956A1 Titanium oxide complex particle, dispersion solution of the particle, and process for production of the particle
11/01/2007WO2007122823A1 Tumor target cell capable of producing vector
11/01/2007WO2007122820A1 Diagnostic agent and therapeutic agent for pancreatic cancer
11/01/2007WO2007122401A1 Imidazole derivatives for use as edg-1 antagonists
11/01/2007WO2007122084A1 Layout of power semiconductor contacts on a cooling surface
11/01/2007WO2007121893A1 Method for treating hpv infected patients
11/01/2007WO2007121883A2 1,4:3,6-dianhydromannitol derivatives and use thereof
11/01/2007WO2007121662A1 Diphenyl urea derivatives as kinase inhibitors, compositions and uses thereof
11/01/2007WO2007121576A1 Methods of inducing apoptosis of cancerous cells using apoptin derivatives
11/01/2007WO2007103727A3 Triterpene derivatives for the treatment of cancer and inflammatory disease by inhibition of nf-kb
11/01/2007WO2007101988A3 Use of tsg-6 for treating bone diseases
11/01/2007WO2007095124A3 Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors
11/01/2007WO2007093519A3 Ibandronate regimen for treating metastatic bone pain
11/01/2007WO2007092379A3 Sesamol derivatives as novel inhibitors of arachidonic acid formation
11/01/2007WO2007088034A3 Tuberous sclerosis treatment
11/01/2007WO2007072503A3 Combinations for managing inflammation and associated disorders
11/01/2007WO2007070319A3 Dibenzonaphthyridine derivatives and methods of use thereof
11/01/2007WO2007068963A3 Therapeutic compositions comprising ingenol-3-angelate
11/01/2007WO2007067730A3 Human monoclonal antibodies to protein tyrosine kinase 7 ( ptk7 ) and their use
11/01/2007WO2007059515A3 Compositions of lipoxygenase inhibitors
11/01/2007WO2006097460A8 Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them
11/01/2007US20070255063 Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors
11/01/2007US20070255055 Epothilone derivatives
11/01/2007US20070255045 O-acetyl-ADP ribose, a histone deacetylase-reaction product, used for producing polyclonal or monoclonal antibodies, and for analysis by competitive binding assaying of aging resistance and/or anticarcinogenic agents
11/01/2007US20070255043 MN gene and protein
11/01/2007US20070254942 1S)-Cyclopropanecarboxylic acid {7-chloro-2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1H-isoindol-4-yl}amide, which may further contain an anticancer agent or an antiinflammatory agent; treating atopic dermatitis, Crohn's disease, and colon cancer
11/01/2007US20070254924 Salts of benzimidazole compound and use thereof
11/01/2007US20070254917 Intracellular receptor modulator compounds and methods
11/01/2007US20070254912 Benzimidazolyl-pyridine compounds for inflammation and immune-related uses
11/01/2007US20070254901 Cancer; 2-(methylthio)-6-phenyl-7-(4-{[4-(5-pyridin-2-yl-4H-1,2,4-triazol-3-yl)piperidin-1-yl]methyl}phenyl)pyrido[2,3-d]pyrimidine;serine/threonine kinase (Akt) suppression; increased cellular potency or solubility, greater selectivity, enhanced pharmacokinetic properties, lack of off target activity
11/01/2007US20070254896 Substituted pyrimidine kinase inhibitors
11/01/2007US20070254893 Combination Product Comprising Src Kinase Inhibitor Azdo530 and an Antioestrogen or Egfr-Tk-Inhibitor
11/01/2007US20070254886 N-[5-bromo-3-({3-[2-(dimethylamino)ethoxy]-4-methoxybenzyl}oxy)pyridin-2-yl]-4-methylbenzenesulfonamide, used for prevention and/or treatment of infections, inflammatory and/or allergic diseases
11/01/2007US20070254883 3-cyclobutyl-1-[(4-phenoxyphenyl)ethynyl]imidazo[1,5-a]pyrazin-8-amine, N-{3-[(8-amino-3-cyclobutylimidazo[1,5-a]pyrazin-1-yl)ethynyl]phenyl}-4-chlorobenzamide; inhibitors of mammalian Target Of Rapamycin (mTOR) kinase; cancer
11/01/2007US20070254878 Administering 1,2,3,6-tetrasubstituted pyrido[3,4-b]indoles to inhibit the 5'-untranslated region-dependent translation; angiogenesis inhibitors; anticarcinogenic agents; retinopathy, rheumatoid arthritis, psoriasis, atherosclerosis, obesity, macular degeneration; may cause hypertension or proteinurea
11/01/2007US20070254875 Androgen Receptor Modulator Compounds and Methods
11/01/2007US20070254871 Compounds for the Treatment of Inflammation of the Central Nervous System
11/01/2007US20070254868 such as 3-(1-(2,3-difluorophenyl)-1H-tetrazol-5-yl)-5-(4-(4-methylpiperazin-1-yl) phenyl)pyridin-2-amine, used as anticarcinogenic agents or for the treatment of atherosclerosis and lung fibrosis
11/01/2007US20070254866 Aminoquinolones as GSK-3 inhibitors
11/01/2007US20070254857 2Alpha-Methyl-19-Nor-(20S)-1Alpha-Hydroxy-Bishomopregnacalciferol and Its Uses
11/01/2007US20070254846 stimulating T-cell transformation; cell proliferative disorder, anti-cancer, and/or anti-sarcoma
11/01/2007US20070254844 biodrug contains an immunogenic peptide; encoded from an isolated host cell transfected with the recombinant expression vector; diagnosis of skin cancer; vaccine for prevention and treatment; immunotherapy
11/01/2007US20070254357 Gene therapy using replication competent targeted adenoviral vectors
11/01/2007US20070254312 Protein Kinase Inhibitors and Methods for Identiying Same
11/01/2007US20070254295 Methods of predicting and monitoring tyrosine kinase inhibitor therapy
11/01/2007US20070254046 such as 4-Aminomethyl-N-[4-(5-biphenyl-4-yl-pyrazolo[1,5-c]pyrimidin-7-ylamino)-phenyl]-benzamide, useful in the therapy of (hyper)proliferative diseases and/or disorders responsive to induction of apoptosis
11/01/2007US20070254037 Methods and Compositions for the Treatment of Cell Proliferation
11/01/2007US20070254034 Activated Foam
11/01/2007US20070254019 Method for treating brain cancer
11/01/2007US20070253970 Enzymatic polypeptide sequences which target and destroy cancer cells
11/01/2007US20070253957 Substituted N-Aryl-1H-Pyrazolo[3,4-B]Quinolin-4-Amines and Analogs as Activators of Caspases and Inducers of Apoptosis
11/01/2007US20070253954 Epha4 As Therapeutic Target Of Prc And Pdaca
11/01/2007US20070253929 Derivatives of growth hormone and related proteins, and methods of use thereof
11/01/2007US20070253898 Polymer based radionuclide containing particulate material
11/01/2007US20070253896 7,9-Dihydro-Purin-8-One and Related Analogs as HSP90-Inhibitors
11/01/2007US20070252295 Amphoteric liposomes containing positive and negative membrane-based or membrane forming charge carriers and having an isoelectric point of between 4 and 8; pH-sensitive liposomes comprise, in particular, cholesterol hemisuccinate
11/01/2007CA2650699A1 Diagnostic agent and therapeutic agent for pancreatic cancer
11/01/2007CA2650057A1 Phenyl- or pyridinyl-amide as inhibitors of c-fms kinase
11/01/2007CA2649924A1 Inhibitors of c-fms kinase
11/01/2007CA2649919A1 Phenyl-and pyridinyl amide inhibitors of c-fms kinase
11/01/2007CA2649800A1 Hgf precursor protein variant and active protein thereof
11/01/2007CA2649755A1 Method of inhibiting c-kit kinase
11/01/2007CA2649739A1 Inhibitors of c-fms kinase
11/01/2007CA2649736A1 Heterocyclic compounds as inhibitors of c-fms kinase
11/01/2007CA2649709A1 Immunoglobulin constant region domains with enhanced stability
11/01/2007CA2649514A1 Licorice polyphenol preparation
11/01/2007CA2649512A1 C-fms kinase inhibitors
11/01/2007CA2648809A1 Indazole compounds and methods for inhibition of cdc7
11/01/2007CA2648558A1 Molecular dissection of the role of the pi3-kinase/akt pathway; redirection from pro-survival signaling to a death pathway through nuclear relocation of akt
11/01/2007CA2645633A1 Combinations of therapeutic agents for treating cancer
11/01/2007CA2644425A1 Novel heteroaryl-substituted arylaminopyridine derivatives as mek inhibitors
10/2007
10/31/2007EP1849865A1 RNAi MEDICINE HAVING NO ADVERSE EFFECTS
10/31/2007EP1849782A1 Quinolinone derivatives as tyrosine kinase inhibitors
10/31/2007EP1849774A1 CYCLOHEPTA(b)PYRIDINE-3-CARBONYLGUANIDINE DERIVATIVE AND PHARMACEUTICAL PRODUCT CONTAINING SAME
1 ... 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 ... 2211